<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[Ligand Pharmaceuticals Inc. | Company News & Executive Profiles - LGND | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/ligand+pharmaceuticals+inc..html?i=11]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for Ligand Pharmaceuticals Inc.]]></description>
	<s:counts start="0" returned="10" found="12" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Ligand Pharmaceuticals Inc. Q2 2009 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-327895.html]]></link>
		<description><![CDATA[ Question-and-Answer Session Operator  Operator Instructions Your first question comes from the line of Joe Pantginis - Merriman Curhan Ford. Joe Pantginis - Merriman Curhan Ford  Just a couple quick questions, obviously the focus is on a lot of your partnered products currently, I am just wondering if...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 03 Aug 2009 18:09:11 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/ligand+pharmaceuticals+inc..html"><![CDATA[Ligand Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/mergers+%2526+acquisitions.html"><![CDATA[Mergers & Acquisitions]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">LGND</category>
		<category domain="tickers">LGND</category>
	</item>
	<item>
		<title><![CDATA[Ligand Pharmaceuticals Inc. Q2 2009 Earnings Call Transcript]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F153434-ligand-pharmaceuticals-inc-q2-2009-earnings-call-transcript%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Ligand Pharmaceuticals Inc. LGND   Q2 2009 Earnings Call Transcript   August 03, 2009 at 4:30 pm ET]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 03 Aug 2009 07:09:11 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/ligand+pharmaceuticals+inc..html"><![CDATA[Ligand Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">LGND</category>
		<category domain="tickers">LGND</category>
	</item>
	<item>
		<title><![CDATA[Ligand Pharmaceuticals Inc. Q1 2009 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-299655.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator instructions Our first question comes from Joe Pantginis from Merriman Curhan Ford. Your line is now open. Joe Pantginis &#8211; Merriman Curhan Ford Hi guys, how are you? Thanks for taking the call. Couple quick questions if you don&#8217;t mind, I guess maybe in the order...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Wed, 06 May 2009 16:40:41 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/hepatitis.html"><![CDATA[Hepatitis]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/schering-plough+corp..html"><![CDATA[Schering-Plough Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/trial.html"><![CDATA[Trial]]></category>
		<category domain="http://resources.bnet.com/topic/ligand+pharmaceuticals+inc..html"><![CDATA[Ligand Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">LGND</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SGP</category>
		<category domain="tickers">LGND,SGP</category>
	</item>
	<item>
		<title><![CDATA[Ligand Pharmaceuticals Incorporated Q4 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-268461.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator Instructions. Your first question comes from Joe Pantginis from Merriman Curhan & Ford. Go ahead sir. Joe Pantginis &#8211; Merriman Curhan Ford & Co. Hi, good afternoon fellows. Thanks for hosing the call and thanks for taking my question. Congratulations on the progress. Can you hear...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 12 Feb 2009 15:15:20 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/wyeth.html"><![CDATA[Wyeth]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/data.html"><![CDATA[Data]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/business+structures.html"><![CDATA[Business Structures]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/ligand+pharmaceuticals+inc..html"><![CDATA[Ligand Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">LGND</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">WYE</category>
		<category domain="tickers">LGND,PFE,WYE</category>
	</item>
	<item>
		<title><![CDATA[Ligand Pharmaceuticals, Inc. Q3 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-251027.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator instructions Your first question comes from Derek Jellinek. Andrew Thorning Hi guys, this is actually Andrew Thorning [ph] for Derek. Just a quick question on PROMACTA, looking at the filing strategy for GSK and sort of the long-term use, I know there was a lot of...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 20 Nov 2008 04:05:33 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/agency.html"><![CDATA[Agency]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/ligand+pharmaceuticals+inc..html"><![CDATA[Ligand Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/gsk.html"><![CDATA[GSK]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/advertising+%2526+promotion.html"><![CDATA[Advertising & Promotion]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[Marketing]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/agency.html"><![CDATA[Agency]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/ligand+pharmaceuticals+inc..html"><![CDATA[Ligand Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/gsk.html"><![CDATA[GSK]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/advertising+%2526+promotion.html"><![CDATA[Advertising & Promotion]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[Marketing]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">LGND</category>
		<category domain="tickers">LGND</category>
	</item>
	<item>
		<title><![CDATA[Ligand Pharmaceuticals, Inc. Q2 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-223766.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator  Thank you. Operator instructions Your first question comes from Derek Jellinek.  Derek Jellinek &#8211; Susquehanna Financial Group  Great. Thanks for taking my question, guys. A couple questions. On 4665, can you maybe talk about the current ongoing trial in ITP, the enrollment that is?...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 25 Aug 2008 08:30:33 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/ligand+pharmaceuticals+inc..html"><![CDATA[Ligand Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">LGND</category>
		<category domain="tickers">LGND</category>
	</item>
	<item>
		<title><![CDATA[Ligand Pharmaceuticals Incorporated Q1 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-226695.html]]></link>
		<description><![CDATA[ Question-and-Answer Session Operator  Operator instructions Your first question comes from the line of David Webber with Broadpoint Capital.  David Webber &#8211; Broadpoint Capital  Thank you.  Couple questions, first just to clarify the projection of $20 million in royalties, is that from AVINZA alone or is...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Tue, 20 May 2008 02:14:08 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/ligand+pharmaceuticals+inc..html"><![CDATA[Ligand Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">LGND</category>
		<category domain="tickers">LGND</category>
	</item>
	<item>
		<title><![CDATA[Ligand Pharmaceuticals Q4 2007 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-229892.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator Instructions. Your first question comes from the line of David Webber with Broadpoint Capital. David Webber - Broadpoint Capital Hi. Just a couple of questions, John. First, I don&#39;t know if you have this information or not, but can you tell us whether the PROMACTA NDA...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Wed, 20 Feb 2008 18:24:08 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/ligand+pharmaceuticals+inc..html"><![CDATA[Ligand Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">LGND</category>
		<category domain="tickers">LGND</category>
	</item>
	<item>
		<title><![CDATA[Back on Nasdaq]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5247/is_25_27/ai_n29276108]]></link>
		<description><![CDATA[Back on Nasdaq: The previously highly troubled Ligand Pharmaceuticals, Inc. began trading again June 14 on the Nasdaq stock exchange.  The San Diego drug development company's common stock was booted to the Pink Sheets in the fall after the firm failed to properly file reports.  Ligand has had...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 19 Jun 2006 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/ligand+pharmaceuticals+inc..html"><![CDATA[Ligand Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">LGND</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">LGND,NDAQ</category>
	</item>
	<item>
		<title><![CDATA[Ligand Pharmaceuticals Inc. Announces Avinza Conference Call; Thursday, March 21, 2002, at 8:30 a.m. ET]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2002_March_20/ai_84032806]]></link>
		<description><![CDATA[Business Editors & Health/Medical Writers  SAN DIEGO--BUSINESS WIRE--March 20, 2002  Ligand Pharmaceuticals Inc. (NASDAQ:LGND), will hold a conference call to discuss AvinzaTM (formerly MorphelanTM) on Thursday, March 21, 2002, at 8:30 a.m. Eastern Time (5:30 a.m. Pacific Time).  This call is being web cast by CCBN and...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 20 Mar 2002 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/fidelity+investments.html"><![CDATA[Fidelity Investments]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/investor.html"><![CDATA[investor]]></category>
		<category domain="http://resources.bnet.com/topic/ligand+pharmaceuticals+inc..html"><![CDATA[Ligand Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">LGND</category>
		<category domain="tickers">LGND</category>
	</item>
</channel>
</rss>
